Global Injectable Anthelmintic Drugs Market Insights, Forecast to 2029
This report presents an overview of global market for Injectable Anthelmintic Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Injectable Anthelmintic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Injectable Anthelmintic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Injectable Anthelmintic Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Injectable Anthelmintic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Injectable Anthelmintic Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck and Boehringer Ingelheim International, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Injectable Anthelmintic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Anthelmintic Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Injectable Anthelmintic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Injectable Anthelmintic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Injectable Anthelmintic Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Injectable Anthelmintic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Injectable Anthelmintic Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck and Boehringer Ingelheim International, etc.
By Company
- Novartis
- Cipla
- Sun Pharmaceutical Industries
- Amneal Pharmaceuticals
- Zoetis
- GlaxoSmithKline
- Bayer
- Merck
- Boehringer Ingelheim International
- Benzimidazoles
- Piperazine
- Imidazothiazole
- Spiroindoles
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Veterinary Pharmacies
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Injectable Anthelmintic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Anthelmintic Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Benzimidazoles
1.2.3 Piperazine
1.2.4 Imidazothiazole
1.2.5 Spiroindoles
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Veterinary Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Injectable Anthelmintic Drugs Market Perspective (2018-2029)
2.2 Global Injectable Anthelmintic Drugs Growth Trends by Region
2.2.1 Injectable Anthelmintic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2018-2023)
2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Injectable Anthelmintic Drugs Market Dynamics
2.3.1 Injectable Anthelmintic Drugs Industry Trends
2.3.2 Injectable Anthelmintic Drugs Market Drivers
2.3.3 Injectable Anthelmintic Drugs Market Challenges
2.3.4 Injectable Anthelmintic Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Injectable Anthelmintic Drugs by Players
3.1.1 Global Injectable Anthelmintic Drugs Revenue by Players (2018-2023)
3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Injectable Anthelmintic Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2022
3.5 Global Key Players of Injectable Anthelmintic Drugs Head office and Area Served
3.6 Global Key Players of Injectable Anthelmintic Drugs, Product and Application
3.7 Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 INJECTABLE ANTHELMINTIC DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2018-2023)
4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2024-2029)
5 INJECTABLE ANTHELMINTIC DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2018-2023)
5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Injectable Anthelmintic Drugs Market Size (2018-2029)
6.2 North America Injectable Anthelmintic Drugs Market Size by Type
6.2.1 North America Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
6.2.2 North America Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
6.2.3 North America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
6.3 North America Injectable Anthelmintic Drugs Market Size by Application
6.3.1 North America Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
6.3.2 North America Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
6.3.3 North America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
6.4 North America Injectable Anthelmintic Drugs Market Size by Country
6.4.1 North America Injectable Anthelmintic Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Injectable Anthelmintic Drugs Market Size by Country (2018-2023)
6.4.3 North America Injectable Anthelmintic Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Injectable Anthelmintic Drugs Market Size (2018-2029)
7.2 Europe Injectable Anthelmintic Drugs Market Size by Type
7.2.1 Europe Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
7.2.2 Europe Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
7.2.3 Europe Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
7.3 Europe Injectable Anthelmintic Drugs Market Size by Application
7.3.1 Europe Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
7.3.2 Europe Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
7.3.3 Europe Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
7.4 Europe Injectable Anthelmintic Drugs Market Size by Country
7.4.1 Europe Injectable Anthelmintic Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Injectable Anthelmintic Drugs Market Size by Country (2018-2023)
7.4.3 Europe Injectable Anthelmintic Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Injectable Anthelmintic Drugs Market Size (2018-2029)
8.2 China Injectable Anthelmintic Drugs Market Size by Type
8.2.1 China Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
8.2.2 China Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
8.2.3 China Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
8.3 China Injectable Anthelmintic Drugs Market Size by Application
8.3.1 China Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
8.3.2 China Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
8.3.3 China Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Injectable Anthelmintic Drugs Market Size (2018-2029)
9.2 Asia Injectable Anthelmintic Drugs Market Size by Type
9.2.1 Asia Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
9.2.2 Asia Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
9.2.3 Asia Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
9.3 Asia Injectable Anthelmintic Drugs Market Size by Application
9.3.1 Asia Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
9.3.2 Asia Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
9.3.3 Asia Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
9.4 Asia Injectable Anthelmintic Drugs Market Size by Region
9.4.1 Asia Injectable Anthelmintic Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Injectable Anthelmintic Drugs Market Size by Region (2018-2023)
9.4.3 Asia Injectable Anthelmintic Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.1.5 Novartis Recent Developments
11.2 Cipla
11.2.1 Cipla Company Details
11.2.2 Cipla Business Overview
11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.2.5 Cipla Recent Developments
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Details
11.3.2 Sun Pharmaceutical Industries Business Overview
11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.3.5 Sun Pharmaceutical Industries Recent Developments
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Details
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.4.5 Amneal Pharmaceuticals Recent Developments
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.5.5 Zoetis Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.7.5 Bayer Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Injectable Anthelmintic Drugs Introduction
11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.8.5 Merck Recent Developments
11.9 Boehringer Ingelheim International
11.9.1 Boehringer Ingelheim International Company Details
11.9.2 Boehringer Ingelheim International Business Overview
11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.9.5 Boehringer Ingelheim International Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Benzimidazoles
1.2.3 Piperazine
1.2.4 Imidazothiazole
1.2.5 Spiroindoles
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Veterinary Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Injectable Anthelmintic Drugs Market Perspective (2018-2029)
2.2 Global Injectable Anthelmintic Drugs Growth Trends by Region
2.2.1 Injectable Anthelmintic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2018-2023)
2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Injectable Anthelmintic Drugs Market Dynamics
2.3.1 Injectable Anthelmintic Drugs Industry Trends
2.3.2 Injectable Anthelmintic Drugs Market Drivers
2.3.3 Injectable Anthelmintic Drugs Market Challenges
2.3.4 Injectable Anthelmintic Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Injectable Anthelmintic Drugs by Players
3.1.1 Global Injectable Anthelmintic Drugs Revenue by Players (2018-2023)
3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Injectable Anthelmintic Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2022
3.5 Global Key Players of Injectable Anthelmintic Drugs Head office and Area Served
3.6 Global Key Players of Injectable Anthelmintic Drugs, Product and Application
3.7 Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 INJECTABLE ANTHELMINTIC DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2018-2023)
4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2024-2029)
5 INJECTABLE ANTHELMINTIC DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2018-2023)
5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Injectable Anthelmintic Drugs Market Size (2018-2029)
6.2 North America Injectable Anthelmintic Drugs Market Size by Type
6.2.1 North America Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
6.2.2 North America Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
6.2.3 North America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
6.3 North America Injectable Anthelmintic Drugs Market Size by Application
6.3.1 North America Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
6.3.2 North America Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
6.3.3 North America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
6.4 North America Injectable Anthelmintic Drugs Market Size by Country
6.4.1 North America Injectable Anthelmintic Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Injectable Anthelmintic Drugs Market Size by Country (2018-2023)
6.4.3 North America Injectable Anthelmintic Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Injectable Anthelmintic Drugs Market Size (2018-2029)
7.2 Europe Injectable Anthelmintic Drugs Market Size by Type
7.2.1 Europe Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
7.2.2 Europe Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
7.2.3 Europe Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
7.3 Europe Injectable Anthelmintic Drugs Market Size by Application
7.3.1 Europe Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
7.3.2 Europe Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
7.3.3 Europe Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
7.4 Europe Injectable Anthelmintic Drugs Market Size by Country
7.4.1 Europe Injectable Anthelmintic Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Injectable Anthelmintic Drugs Market Size by Country (2018-2023)
7.4.3 Europe Injectable Anthelmintic Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Injectable Anthelmintic Drugs Market Size (2018-2029)
8.2 China Injectable Anthelmintic Drugs Market Size by Type
8.2.1 China Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
8.2.2 China Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
8.2.3 China Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
8.3 China Injectable Anthelmintic Drugs Market Size by Application
8.3.1 China Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
8.3.2 China Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
8.3.3 China Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Injectable Anthelmintic Drugs Market Size (2018-2029)
9.2 Asia Injectable Anthelmintic Drugs Market Size by Type
9.2.1 Asia Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
9.2.2 Asia Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
9.2.3 Asia Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
9.3 Asia Injectable Anthelmintic Drugs Market Size by Application
9.3.1 Asia Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
9.3.2 Asia Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
9.3.3 Asia Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
9.4 Asia Injectable Anthelmintic Drugs Market Size by Region
9.4.1 Asia Injectable Anthelmintic Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Injectable Anthelmintic Drugs Market Size by Region (2018-2023)
9.4.3 Asia Injectable Anthelmintic Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.1.5 Novartis Recent Developments
11.2 Cipla
11.2.1 Cipla Company Details
11.2.2 Cipla Business Overview
11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.2.5 Cipla Recent Developments
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Details
11.3.2 Sun Pharmaceutical Industries Business Overview
11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.3.5 Sun Pharmaceutical Industries Recent Developments
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Details
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.4.5 Amneal Pharmaceuticals Recent Developments
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.5.5 Zoetis Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.7.5 Bayer Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Injectable Anthelmintic Drugs Introduction
11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.8.5 Merck Recent Developments
11.9 Boehringer Ingelheim International
11.9.1 Boehringer Ingelheim International Company Details
11.9.2 Boehringer Ingelheim International Business Overview
11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2018-2023)
11.9.5 Boehringer Ingelheim International Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Benzimidazoles
Table 3. Key Players of Piperazine
Table 4. Key Players of Imidazothiazole
Table 5. Key Players of Spiroindoles
Table 6. Key Players of Others
Table 7. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Injectable Anthelmintic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2018-2023)
Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2024-2029)
Table 13. Injectable Anthelmintic Drugs Market Trends
Table 14. Injectable Anthelmintic Drugs Market Drivers
Table 15. Injectable Anthelmintic Drugs Market Challenges
Table 16. Injectable Anthelmintic Drugs Market Restraints
Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Injectable Anthelmintic Drugs Revenue Share by Players (2018-2023)
Table 19. Global Top Injectable Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2022)
Table 20. Global Injectable Anthelmintic Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Injectable Anthelmintic Drugs, Headquarters and Area Served
Table 23. Global Key Players of Injectable Anthelmintic Drugs, Product and Application
Table 24. Global Key Players of Injectable Anthelmintic Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2024-2029)
Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Injectable Anthelmintic Drugs Revenue Share by Application (2018-2023)
Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Injectable Anthelmintic Drugs Revenue Share by Application (2024-2029)
Table 34. North America Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Injectable Anthelmintic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Injectable Anthelmintic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Injectable Anthelmintic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Injectable Anthelmintic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Injectable Anthelmintic Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Injectable Anthelmintic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Injectable Anthelmintic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Injectable Anthelmintic Drugs Product
Table 69. Novartis Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Developments
Table 71. Cipla Company Details
Table 72. Cipla Business Overview
Table 73. Cipla Injectable Anthelmintic Drugs Product
Table 74. Cipla Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 75. Cipla Recent Developments
Table 76. Sun Pharmaceutical Industries Company Details
Table 77. Sun Pharmaceutical Industries Business Overview
Table 78. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product
Table 79. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 80. Sun Pharmaceutical Industries Recent Developments
Table 81. Amneal Pharmaceuticals Company Details
Table 82. Amneal Pharmaceuticals Business Overview
Table 83. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product
Table 84. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 85. Amneal Pharmaceuticals Recent Developments
Table 86. Zoetis Company Details
Table 87. Zoetis Business Overview
Table 88. Zoetis Injectable Anthelmintic Drugs Product
Table 89. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 90. Zoetis Recent Developments
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Injectable Anthelmintic Drugs Product
Table 94. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 95. GlaxoSmithKline Recent Developments
Table 96. Bayer Company Details
Table 97. Bayer Business Overview
Table 98. Bayer Injectable Anthelmintic Drugs Product
Table 99. Bayer Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 100. Bayer Recent Developments
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Injectable Anthelmintic Drugs Product
Table 104. Merck Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 105. Merck Recent Developments
Table 106. Boehringer Ingelheim International Company Details
Table 107. Boehringer Ingelheim International Business Overview
Table 108. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product
Table 109. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 110. Boehringer Ingelheim International Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Benzimidazoles
Table 3. Key Players of Piperazine
Table 4. Key Players of Imidazothiazole
Table 5. Key Players of Spiroindoles
Table 6. Key Players of Others
Table 7. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Injectable Anthelmintic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2018-2023)
Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2024-2029)
Table 13. Injectable Anthelmintic Drugs Market Trends
Table 14. Injectable Anthelmintic Drugs Market Drivers
Table 15. Injectable Anthelmintic Drugs Market Challenges
Table 16. Injectable Anthelmintic Drugs Market Restraints
Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Injectable Anthelmintic Drugs Revenue Share by Players (2018-2023)
Table 19. Global Top Injectable Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2022)
Table 20. Global Injectable Anthelmintic Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Injectable Anthelmintic Drugs, Headquarters and Area Served
Table 23. Global Key Players of Injectable Anthelmintic Drugs, Product and Application
Table 24. Global Key Players of Injectable Anthelmintic Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2024-2029)
Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Injectable Anthelmintic Drugs Revenue Share by Application (2018-2023)
Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Injectable Anthelmintic Drugs Revenue Share by Application (2024-2029)
Table 34. North America Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Injectable Anthelmintic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Injectable Anthelmintic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Injectable Anthelmintic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Injectable Anthelmintic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Injectable Anthelmintic Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Injectable Anthelmintic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Injectable Anthelmintic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Injectable Anthelmintic Drugs Product
Table 69. Novartis Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Developments
Table 71. Cipla Company Details
Table 72. Cipla Business Overview
Table 73. Cipla Injectable Anthelmintic Drugs Product
Table 74. Cipla Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 75. Cipla Recent Developments
Table 76. Sun Pharmaceutical Industries Company Details
Table 77. Sun Pharmaceutical Industries Business Overview
Table 78. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product
Table 79. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 80. Sun Pharmaceutical Industries Recent Developments
Table 81. Amneal Pharmaceuticals Company Details
Table 82. Amneal Pharmaceuticals Business Overview
Table 83. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product
Table 84. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 85. Amneal Pharmaceuticals Recent Developments
Table 86. Zoetis Company Details
Table 87. Zoetis Business Overview
Table 88. Zoetis Injectable Anthelmintic Drugs Product
Table 89. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 90. Zoetis Recent Developments
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Injectable Anthelmintic Drugs Product
Table 94. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 95. GlaxoSmithKline Recent Developments
Table 96. Bayer Company Details
Table 97. Bayer Business Overview
Table 98. Bayer Injectable Anthelmintic Drugs Product
Table 99. Bayer Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 100. Bayer Recent Developments
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Injectable Anthelmintic Drugs Product
Table 104. Merck Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 105. Merck Recent Developments
Table 106. Boehringer Ingelheim International Company Details
Table 107. Boehringer Ingelheim International Business Overview
Table 108. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product
Table 109. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2018-2023) & (US$ Million)
Table 110. Boehringer Ingelheim International Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Injectable Anthelmintic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Benzimidazoles Features
Figure 4. Piperazine Features
Figure 5. Imidazothiazole Features
Figure 6. Spiroindoles Features
Figure 7. Others Features
Figure 8. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Injectable Anthelmintic Drugs Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Veterinary Pharmacies Case Studies
Figure 14. Others Case Studies
Figure 15. Injectable Anthelmintic Drugs Report Years Considered
Figure 16. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Injectable Anthelmintic Drugs Market Share by Region: 2022 VS 2029
Figure 19. Global Injectable Anthelmintic Drugs Market Share by Players in 2022
Figure 20. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2022
Figure 22. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 24. North America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 25. North America Injectable Anthelmintic Drugs Market Share by Country (2018-2029)
Figure 26. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 29. Europe Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 30. Europe Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 31. Europe Injectable Anthelmintic Drugs Market Share by Country (2018-2029)
Figure 32. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. China Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. China Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 40. China Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 41. Asia Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 42. Asia Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 43. Asia Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 44. Asia Injectable Anthelmintic Drugs Market Share by Region (2018-2029)
Figure 45. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. China Taiwan Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. India Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 53. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 54. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Country (2018-2029)
Figure 55. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Israel Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. GCC Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 62. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 63. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 64. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 65. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 67. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 69. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Figure 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Injectable Anthelmintic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Benzimidazoles Features
Figure 4. Piperazine Features
Figure 5. Imidazothiazole Features
Figure 6. Spiroindoles Features
Figure 7. Others Features
Figure 8. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Injectable Anthelmintic Drugs Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Veterinary Pharmacies Case Studies
Figure 14. Others Case Studies
Figure 15. Injectable Anthelmintic Drugs Report Years Considered
Figure 16. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Injectable Anthelmintic Drugs Market Share by Region: 2022 VS 2029
Figure 19. Global Injectable Anthelmintic Drugs Market Share by Players in 2022
Figure 20. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2022
Figure 22. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 24. North America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 25. North America Injectable Anthelmintic Drugs Market Share by Country (2018-2029)
Figure 26. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 29. Europe Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 30. Europe Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 31. Europe Injectable Anthelmintic Drugs Market Share by Country (2018-2029)
Figure 32. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. China Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. China Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 40. China Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 41. Asia Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 42. Asia Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 43. Asia Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 44. Asia Injectable Anthelmintic Drugs Market Share by Region (2018-2029)
Figure 45. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. China Taiwan Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. India Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Type (2018-2029)
Figure 53. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Application (2018-2029)
Figure 54. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Country (2018-2029)
Figure 55. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Israel Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. GCC Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 62. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 63. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 64. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 65. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 67. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 69. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
